Mpox in Europe, 2022–2026: A Scoping Review of Viral Clades, Host Determinants of Severity and Antiviral Therapy

Filippos Sofos, Zoi D. Pana, Dimitris Drikakis

Open source

DOI
10.3390/v18080865
Published
2026-08-07
Container
Viruses
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/v18080865,
  title = {Mpox in Europe, 2022–2026: A Scoping Review of Viral Clades, Host Determinants of Severity and Antiviral Therapy},
  author = {Filippos Sofos and Zoi D. Pana and Dimitris Drikakis},
  year = {2026},
  journal = {Viruses},
  doi = {10.3390/v18080865},
  url = {https://doi.org/10.3390/v18080865}
}

RIS

TY  - JOUR
TI  - Mpox in Europe, 2022–2026: A Scoping Review of Viral Clades, Host Determinants of Severity and Antiviral Therapy
AU  - Filippos Sofos
AU  - Zoi D. Pana
AU  - Dimitris Drikakis
PY  - 2026
JO  - Viruses
DO  - 10.3390/v18080865
UR  - https://doi.org/10.3390/v18080865
ER  - 

APA

Sofos, F., Pana, Z. D., & Drikakis, D. (2026). Mpox in Europe, 2022–2026: A Scoping Review of Viral Clades, Host Determinants of Severity and Antiviral Therapy. Viruses. https://doi.org/10.3390/v18080865

Source records